Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.48 USD | -4.64% | -14.06% | +59.78% |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.78% | 163.26Cr | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+42.72% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- JPMorgan Adjusts Price Target on Edgewise Therapeutics to $25 From $24, Maintains Overweight Rating